{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:56:46Z","timestamp":1778914606546,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s13365-019-00738-x","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T09:48:22Z","timestamp":1552384102000},"page":"284-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Progressive multifocal leukoencephalopathy treated with nivolumab"],"prefix":"10.1007","volume":"25","author":[{"given":"Ethan","family":"Hoang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu S.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-1555","authenticated-orcid":false,"given":"David B.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"738_CR1","doi-asserted-by":"crossref","unstructured":"Clifford DB (2015) Progressive multifocal leukoencephalopathy therapy. J Neurovirol 21(6):632\u2013636","DOI":"10.1007\/s13365-014-0289-8"},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1002\/ana.24769","volume":"80","author":"I Cortese","year":"2016","unstructured":"Cortese I, Smith B, Schindler M, Ohayon J, Monaco MC, Ryschkewitsch C et al (2016) M145 - treatment of progressive multifocal leukoencephalopathy with pembrolizumab, a PD-1 inhibitor. Ann Neurol 80:S166\u2013S167","journal-title":"Ann Neurol"},{"issue":"5","key":"738_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/eji.201646875","volume":"47","author":"L Dyck","year":"2017","unstructured":"Dyck L, Mills KHG (2017) Immune checkpoints and their inhibition in cancer and infectious diseases. Eur J Immunol 47(5):765\u2013779","journal-title":"Eur J Immunol"},{"issue":"11","key":"738_CR4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1212\/WNL.0000000000004369","volume":"89","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Evoli A (2017) Immune checkpoint inhibitor therapy: a double-edged sword? Neurology 89(11):1101\u20131102","journal-title":"Neurology"},{"issue":"8","key":"738_CR5","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3201\/eid2408.180460","volume":"24","author":"M Martinot","year":"2018","unstructured":"Martinot M, Ahle G, Petrosyan I, Martinez C, Gorun DM, Mohseni-Zadeh M et al (2018) Progressive multifocal leukoencephalopathy after treatment with nivolumab. Emerg Infect Dis 24(8):1594\u20131596","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"738_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ana.22408","volume":"70","author":"FJ Mateen","year":"2011","unstructured":"Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, Gould MS, Clifford DB, Nath A (2011) Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70(2):305\u2013322","journal-title":"Ann Neurol"},{"issue":"2","key":"738_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciy074","volume":"67","author":"H Melliez","year":"2018","unstructured":"Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P et al (2018) Risk of progressive multifocal leukoencephalopathy in the combination antiretroviral therapy era in the French hospital database on human immunodeficiency virus (ANRS-C4). Clin Infect Dis 67(2):275\u2013282","journal-title":"Clin Infect Dis"},{"issue":"23","key":"738_CR8","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/bloodadvances.2017008201","volume":"1","author":"EC Neil","year":"2017","unstructured":"Neil EC, DeAngelis LM (2017) Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood Adv 1(23):2041\u20132045","journal-title":"Blood Adv"},{"issue":"2","key":"738_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD (2018) Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378(2):158\u2013168","journal-title":"N Engl J Med"},{"key":"738_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijid.2017.01.028","volume":"56","author":"M Rao","year":"2017","unstructured":"Rao M, Valentini D, Dodoo E, Zumla A, Maeurer M (2017) Anti-PD-1\/PD-L1 therapy for infectious diseases: learning from the cancer paradigm. Int J Infect Dis 56:221\u2013228","journal-title":"Int J Infect Dis"},{"issue":"3","key":"738_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/QAI.0b013e31825a313c","volume":"60","author":"CS Tan","year":"2012","unstructured":"Tan CS, Bord E, Broge TA Jr, Glotzbecker B, Mills H, Gheuens S et al (2012) Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr 60(3):244\u2013248","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-019-00738-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:10:42Z","timestamp":1583871042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-019-00738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1007\/s13365-019-00738-x","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"5 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}